Research Roundup

Debbie Rigby takes a look at the latest in research news Safety of Proton Pump Inhibitors in patients receiving rivaroxaban or aspirin In a large placebo-controlled randomized trial, pantoprazole was not associated with any adverse event when used for 3 years, with the possible exception of an increased risk of enteric infections. C difficile infection